Selected Reading
- Bhatia R, Verfaillie CM: Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores β1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors. Blood 91: 3414, 1998
- Calabretta B et al: Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: An in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA 88: 2351, 1991
- Crooke ST: An overview of progress in antisense therapeutics. Antisense Nucleic Acid Drug Dev 8: 115, 1998
- Gewirtz AM, Sokol DL, Ratajczak MZ: Nucleic acid therapeutics: State of the art and future prospects. Blood 92: 712, 1998
- Gewirtz AM et al: Oligodeoxynucleotide therapeutics for human myelogenous leukemia: Interim results. Blood 88: 270a, 1996
- Goldman JM: Chronic myeloid leukemia. Curr Opin Hematol 4:277, 1997
- Neckers LM: Oligodeoxynucleotide Inhibitors of function: mRNA and protein interactions. Cancer J Sci Am 4 (Suppl 1): S35, 1998
- Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132: 1497, 1960